Sanara Medtech Inc. · NASDAQ:SMTI
Sanara Medtech — Wound Management Technologies — Investor Presentation (June 2009)
14 slides from Sanara Medtech's investor presentation, Jun 18, 2009
Slide 1: Wound Management Technologies, Inc.
Wound Management Technologies, Inc. (OTC BB: WNDM) Leading licensor, provider and distributor of wound care products to healthcare providers (physicians, clinics, hospitals, homecare, long term care and DME), and a vast secondary consumer market.
Slide 2: Disclaimer
Disclaimer® This presentation contains forward-looking statements, including financial and other information relating to Wound Management Technologies (The Company). The information has been assembled by the Company solely for informational purposes and does not purport to contain all information th
Slide 3: Executive Overview
Executive Overview > — Wound Management Technology, Inc. (TK: WNDM.0b), through its wholly owned subsidiary, Wound Care Innovations LLC, is a leading provider of wound care products to direct users and distributors in the wound market place. > — Market capitalization: $73.5 million (Stock price: $2.
Slide 4: Wound Care Innovations, LLC
Wound Care Innovations, LLC ‘Wound Care Innovations, LLC a wholly owned subsidiary of Wound Management Technology, Inc. brings to the wound care arena a unique and dynamic mix of expertise, products, procedures and service. The patented Activated Collagen found in CellerateRX® products is ideally pr
Slide 5: Why CellerateRX
Why CellerateRXx® > Until now, collagen has always been presented to the body in an intact, native form which requires days for the body to break down and prepare the collagen for use. > The patented Activated Collagen found in CellerateRX® products is ideally prepared for immediate use by the body,
Slide 6: Product Expansion / Business Development
Product Expansion / Business Development >» — The Company is deep in discussions to acquire additional products that are focused on the wound care market: - CellerateRX with PSGAG (Polysulfated Glycosaminoglycan) - PSGAG - Shingles pain product - Bonewax > The Company is also looking to further its
Slide 7: Product Distribution
Product Distribution >» The Company has been significantly expanding its product distribution globally, based on the release of its latest evidence based studies. > Partnered with IMCO, a major global distributor, with 2008 Gross Revenue of $2.38 supporting over 1,000 independent distributors > — Cu
Slide 8: Wound Care Market Place
Wound Care Market Place > — Our immediate market is the multi-billion dollar domestic and international wound care market. > Primary buyers include physicians, clinics, hospitals, homecare, long term care and DME. > — Wound Care Innovations was formed with the sole purpose of bringing CellerateRX® a
Slide 9: According to the ADA, approximately 23.6 million people with diabetes
According to the ADA, there are approximately 23.6 million people with diabetes It is estimated that 15-20% of these will develop a foot ulcer at some point in their lifetime 60% of LEAs occur in people with DM 85% of LEAs are preceded by foot ulcers Diabetic foot ulcers lead to over 82,000 amputati
Slide 10: Market Projections
Market Projections United Statement Market US. market for advanced wound care technologies is estimated to grow at an average annual growth rate of 12.3% over the next 5 years to reach over $4.6 billion, Middle East Statement Market Saudi Arabia, a country of over 12 milion people, is a rapidly deve
Slide 11: Executive Team
Executive Team ‘Scott Haire — CEO / Chairman: Scott is founder of Wound Management Technologies, Inc. Prior to founding the business he was an employee of the Wound Care Innovations from November 1993 to June 1994. Previously, Scott was president of Preferred Payment Systems, 2 company specializing
Slide 12: Corporate Resources
Corporate Resources ‘The Company has very strong partners that will enable them to significantly expand the business as opportunities present themselves. CPA (GAP) - Evans, Mills, and Warriner (Barbersville, KY) CPA (Audits) - Pritcher, Siler, and Hardy (Salt Lake City, UT) > Legal Counsel - Jackson
Slide 13: Financial Projections and Share Structure
(080.1 rears) 2008 2009 Gross Revenue 290 9,000 Net Income (800) 4,700 ‘Share Structure (As of 31 Dec 2008) > — Outstanding shares: 27,237,310 >» Public float shares: 1,868,582 WNDM is currently in the process of moving from OTC:88 to either AMEX or NASDAQ by end of Q409 Estimated Sales & Net Income
Slide 14: Roadmap — 2009 - 2010
Roadmap — 2009 - 2010 > Specialized approach to the diabetic and hard to treat wound marketplace > Partnered with IMCO, a major global distributor, with 2008 Gross Revenue of $2.3 billion supporting over 1,000 independent distributors > In mutiple discussions with distributors in Europe, Middle East
Wound Management Technologies — Investor Presentation (June 2009) on 6ix